MEDICAL EQUIPMENT
AND CONNECTED DEVICES

The New way of Clinical Trials:

The clinical trials industry is changing. As an equipment provider for clinical studies, Clinichain identifies that the industry is operating more remote, more data-driven and has become homebased. We experience an increasing amount of studies involving a wearable monitoring device and connected devices, through which patients can receive feedback from their researchers and site personnel. The personalized data generated by the app itself is used to read out clinical outcomes. Throughout this innovative approach, the journey from lab to patient will shorten. This means faster development of new medicines and treatments.

Home based Trials

Wearables have the potential to overcome several challenges related to clinical trials. They improve execution by increasing patients’ ability to participate, they drive patient engagement, and create more opportunities for decentralized trial sites. Measurements can be done continuously and results in more reliable clinical result outcomes.

Global equipment rental service

Clinichain provides timely access to medical equipment and support logistic needs, compliant to the sunshine act. Our tailored rental solutions adapt to your clinical trial phase, geographic complexities and allow for delays and early terminations. We can provide medical equipment for drug development in over 150 countries. Having built a strong network of local equipment agents and brokers, we can deliver medical equipment on site, when needed, worldwide.

For more information about Clinichain:

www.clinichain.com

Go to article: Home | The dengue dilemma Go to article: In this issueGo to article: Owen MumfordGo to article: ContentsGo to article: Hapa Company Insight Go to article: Daiichi JitsugyoGo to article: NewsGo to article: EmbocapsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: The pharma industry briefingGo to article: Dow Europe Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The problem of manipulated data Go to article: Capsugel Company Insight Go to article: CapsugelGo to article: Timeline: the dengue vaccine dilemmaGo to article: TSS Company Insight Go to article: TSSGo to article: From evergreening to thicketing: exploring manipulation of the pharma patent sysGo to article: Emirates SkyCargoGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Swiss WorldCargoGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company Insight Go to article: Nelson LabsGo to article: Treading the line: the challenge of transplant rejection drugsGo to article: Corbion PuracGo to article: Erdmann Design Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Treating menopause: at last a non-hormonal alternative? Go to article: YourwayGo to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Drug repurposing: the industry’s all-rounder medicinesGo to article: FargoGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: One step closer to a Chlamydia vaccine Go to article: AralabGo to article: Synex SyntheticsGo to article: Deals in brief powered by GlobalDataGo to article: Charles Ischi Go to article: The key list powered by GlobalDataGo to article: Pharmaceutical Solutions IndustryGo to article: Clinichain Company Insight Go to article: ClinichainGo to article: SanofiGo to article: EventsGo to article: NymiGo to article: Modality SolutionsGo to article: PfanstiehlGo to article: Next issueGo to article: MimotopesGo to article: ICCI - International Cannabis and Cannabinoids Institute Go to article: ICCI